Navigation Links
ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives
Date:1/29/2009

PROGRAMS INCLUDE BONE MARROW CLINICAL TRIAL IN ITALY

RANCHO CORDOVA, Calif., Jan. 29 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today that its MarrowXpress(TM) (MXP(TM)) device is now being used in two new regenerative medicine programs.

These efforts include use of the MXP, which is used to concentrate stem cells from bone marrow, in an ongoing Phase II clinical trial being conducted at the University of Naples in Italy to study the effect of bone marrow derived mononuclear cells on patients with critical limb ischemia (CLI). In addition, ThermoGenesis announced the launch of its distribution agreement with Celling Technologies, an orthopedics company focusing on the cell therapy market.

The University of Naples trial will involve 30 patients and include 12-month follow-up to determine the impact of the treatment. The lead investigators are Dr. Gilda Cobellis and Professor Vincenzo Sica, who has been treating CLI patients with mononuclear cells derived from bone marrow for several years. The early results from his efforts indicate the treatment has resulted in significant improvement in patients' clinical status. The trial in Naples represents the first human use of the ThermoGenesis MXP System for the treatment of CLI patients.

Within one year of being diagnosed with CLI, 40-50 percent of the more than 20 million patients suffering from diabetes in the U.S. will experience a major amputation. The utility of bone marrow derived stem cells to prevent amputation by restoring blood flow to the affected limb is being studied in a number of clinical settings.

"We are pleased that our new MXP System has been selected for this CLI trial with the University of Naples,
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection
2. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
3. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
4. Impact Medical Solutions Announces Appointment of New Director and Corporate Update
5. Oncolytics Biotech Inc. Announces Start of Patient Enrolment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients with Metastatic Colorectal Cancer
6. ISTA Pharmaceuticals Announces Positive Results for Phase IIb Study of Ecabet Sodium
7. Immunomedics Announces Preclinical Therapy Results of SN-38 Immunoconjugate for Colorectal Cancer
8. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
9. Kyowa Hakko Kirin Announces Development Policy for Anti-Parkinsons Disease Drug KW-6002 (Istradefylline)
10. Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
11. Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014 Research and ... Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market ... For the purposes of this report, the human microbiome ... The human microbiome market is expected to be valued ... at a CAGR of 22.3% within the forecast period of ...
(Date:9/19/2014)... , Sept. 19, 2014 Five MinuteClinic walk-in medical ... Memphis metropolitan area. Three clinics opened in ... month. A fourth clinic will be added in Springfield ... Bartlett is expected to open October 22.  MinuteClinic ... in the United States . The ...
(Date:9/19/2014)... Sept. 19, 2014  Lpath, Inc. (NASDAQ: ... lipid-targeted therapeutics, announced today that it has entered ... of common stock and 3,605,042 unregistered warrants in ... for one registered share of common stock and ... of common stock will be $3.475.  The warrants ...
Breaking Medicine Technology:Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 2Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 3MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3
... 2011 Volcano Corporation (NASDAQ: VOLC ), ... and therapy guidance tools designed to enhance the treatment ... it will be participating in two upcoming investor conferences. ... participate in the Stifel Nicolaus Healthcare Conference 2011. The ...
... Sept. 1, 2011 /PRNewswire-Asia/ -- China Botanic Pharmaceutical ... Botanic" or the "Company"), a developer, manufacturer and ... medicines ("TCM") in China, today announced that the ... a key research laboratory ("the laboratory") in cooperation ...
Cached Medicine Technology:Volcano Corporation Announces Presentations at Upcoming Investor Conferences 2China Botanic Pharmaceutical Enters into Research Cooperation with Key Laboratory of Forest Plant Ecology 2China Botanic Pharmaceutical Enters into Research Cooperation with Key Laboratory of Forest Plant Ecology 3
(Date:9/20/2014)... September 21, 2014 6 Minutes to ... fitness expert Craig Ballantyne that is showing men and women ... blast away stubborn body fat using simple 6-minute exercises and ... Michaels, prompting an investigative review. , “When it comes ... in vs. calories out for all people,” reports Michaels. “Metabolism ...
(Date:9/20/2014)... Melbourne, Australia (PRWEB) September 21, 2014 ... levels are contributing to greater waste treatment volumes. ... are increasingly diverting waste from landfill. According to ... decade, governments have implemented strategies aimed at reducing ... amount of waste recycled and recovered.” Still, a ...
(Date:9/20/2014)... September 20, 2014 As testosterone ... in federal court, Bernstein Liebhard LLP notes that ... (FDA) have voted overwhelmingly to recommend that prescription ... be subjected to further study in order to ... published on September 18th by Bloomberg.com, the panel ...
(Date:9/20/2014)... Sept. 20, 2014 (HealthDay News) -- As flu season ... infection is to get a flu shot and a ... A primary care doctor can vaccinate people against the ... patients may have. Retail stores may provide flu shots ... advice, said Dr. Jorge Parada, medical director of infection ...
(Date:9/20/2014)... York (PRWEB) September 20, 2014 ... ( http://www.injurybeacon.com/power-morcellator/ ) in gynecological surgeries continue ... another insurer has announced plans to end coverage ... on its website last month, Harrisburg, Pennsylvania-based Capital ... November 1, 2014. The insurer said its decision ...
Breaking Medicine News(10 mins):Health News:6 Minutes to Skinny: Review Exposes Craig Ballantyne’s Method to Jump Starting the Metabolism and Blasting Away Body Fat in Just 6 Minutes Per Day 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 2Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 3Health News:Get a Flu Shot During Checkup, Doctor Says 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 3
... acids help new moms fight depression, according to a new ... Journal. ,"Depression in new mothers is common ... percent of postpartum women. In some high-risk populations, the percentage ... percent. Since depression has devastating effects on both mother and ...
... the home clearly raise the risk of the allergic sensitisation ... older children , however, the influence of the environment at ... This is the conclusion reached by scientists from the GSF ... ,The study published by Chih-Mei Chen et ...
... gay governor, James E. McGreevy appears to be knocking on ... in the news for the right reasons. He has ... ,Former Gov. James E. McGreevy, who was brought up ... religion on Sunday at St. Bartholomew's Church in New York. ...
... of IT students here have developed a device that can enable ... ,Called 'E-Netra', it costs Rs.2,000-3,000 and it reads texts through ... heard through earphones. ,Right now it can only ... in Braille script. ,The Agra College team that took ...
... the information furnished by Indira Gandhi National Open University ... Parliament/State legislature or deemed to be university can ... norms and guidelines laid down by the Distance Education ... meeting held on March 23, 2007 had resolved that ...
... from 105 countries met Friday to formally adopt a 24-page ... global warming after five days of heated debate to reaching ... at 3:30 a.m. Friday," said Carloa Traverso Saibante, information officer ... ,Once the IPCC report is formally adopted, it will ...
Cached Medicine News:Health News:Breastfeeding and Omega-3 Fatty Acids Help New Moms Fight Depression 2Health News:Cats at Home Poses Allergy Risk in Young Children 2Health News:Climate Talks Reach Consensus in Bangkok 2
... Inserted into the punctal opening to ... collagen plugs provide temporary relief of ... precisely measured premium collagen, Used as ... occlusion, Available in standard and short ...
... head combined with a softer more flexible ... design simplifies insertion and the large anchor ... dislocation less likely. The inserter provides ... SOFT PLUG Silicone Plugs are removable. Available ...
Attain Left-heart Lead Delivery Systems. Medtronic offers left-heart lead delivery systems to assist with accessing the coronary sinus (cs)....
Attain CS Leads. Navigate minimally angled veins with no tortuosity....
Medicine Products: